Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded
- Contract number
- SPE2DX25FVKBR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $21,420
Award facts
- Contract value 100% obligated
- $21,420.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Kesimpta 20 mg/0.4 mL pen injectors. This firm fixed-price delivery order, valued at $21.4K, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded without set-aside designation and is scheduled for completion by September 19, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Kesimpta is a specialty pharmaceutical product used in the treatment of multiple sclerosis, reflecting the federal government's procurement of specialized neurological medications through its pharmaceutical distribution network.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a $1 billion prime IDC with DLA valued through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. This prime contract enables the company to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support Defense Health Agency and other federal healthcare customers worldwide. The current delivery order exemplifies AmerisourceBergen's role as a critical vendor within the federal medical procurement system, leveraging its extensive IDC to fulfill specialized pharmaceutical requirements for military and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DX25FVKBR?
SPE2DX25FVKBR was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 18, 2025.
How much is contract SPE2DX25FVKBR worth?
The government has obligated $21,420 on SPE2DX25FVKBR.
Is contract SPE2DX25FVKBR an order under another contract?
Yes. SPE2DX25FVKBR is a delivery order under SPE2DX15D1022, an indefinite delivery contract.
Was contract SPE2DX25FVKBR competed?
The extent of competition for SPE2DX25FVKBR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award